Reaction Details |
| Report a problem with these data |
Target | Cyclin-dependent kinase 9 |
---|
Ligand | BDBM50570974 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_2113477 (CHEMBL4822327) |
---|
Kd | 1065±n/a nM |
---|
Citation | King, HM; Rana, S; Kubica, SP; Mallareddy, JR; Kizhake, S; Ezell, EL; Zahid, M; Naldrett, MJ; Alvarez, S; Law, HC; Woods, NT; Natarajan, A Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax. Bioorg Med Chem Lett43:0 (2021) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cyclin-dependent kinase 9 |
---|
Name: | Cyclin-dependent kinase 9 |
Synonyms: | C-2K | CDC2L4 | CDK9 | CDK9_HUMAN | Cell division cycle 2-like protein kinase 4 | Cell division protein kinase 9 | Cyclin-Dependent Kinase 9 (CDK9) | Cyclin-dependent kinase 9 (CDK9) | Serine/threonine-protein kinase PITALRE | TAK | Tat-associated kinase complex catalytic subunit |
Type: | Enzyme Subunit |
Mol. Mass.: | 42789.13 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 372 |
Sequence: | MAKQYDSVECPFCDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFP
ITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK
FTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS
QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLAL
ISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDP
AQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSRNP
ATTNQTEFERVF
|
|
|
BDBM50570974 |
---|
n/a |
---|
Name | BDBM50570974 |
Synonyms: | CHEMBL4846069 |
Type | Small organic molecule |
Emp. Form. | C16H19N3O2 |
Mol. Mass. | 285.341 |
SMILES | COc1ccc(CC(=O)Nc2cc([nH]n2)C2CCC2)cc1 |
Structure |
|